Diagnostic News and Research

RSS

Genetic tests find skeletons like incest in the family: Study

Researchers at Baylor College of Medicine in Houston have developed sophisticated DNA analyses that can detect disabilities as birth defects, epilepsy or developmental delays. They note that about 25 percent of genetic material inherited from their mother was the same as material inherited from their father. This denoted incest. This has triggered ethical debates over how these inadvertent findings should be handled.

13 Feb 2011

53 share a needle & HIV risk due to a clinic blunder

Over 50 patients at a private radiology clinic were given blood tests using a needle device meant for single-patient use. Authorities have launched an investigation into the matter. These patients are all at risk of hepatitis B, hepatitis C and HIV infection. These cancer patients will need testing for the viruses, and again in three months. They had visited the hospital for a positron emission tomography (PET) scan for cancer detection.

13 Feb 2011

NIH awards Geospiza phase II SBIR grant to develop new DNA variant application for GeneSifter platform

Geospiza, Inc. the market leading developer of the GeneSifter® software platform for genetic analysis, today announced that the National Human Genome Research Institute of the National Institutes of Health has awarded the company a phase II SBIR grant to collaborate with researchers at Weil Cornell Medical College, Mayo Clinic to develop a new application that quickly identifies and visualizes DNA sequence variations found when comparing normal and cancer tissues using Geospiza's GeneSifter cloud computing platform.

11 Feb 2011

Imaging Diagnostic Systems completes installation of CTLM breast imaging system in Jakarta, Indonesia

Imaging Diagnostic Systems, Inc., a pioneer in laser breast imaging, announced today that it has completed installation and training for its (CTLM®) in Jakarta, Indonesia at the Hang Lekiu Medical Center.

11 Feb 2011

Scientists discover new method for early diagnosis, treatment of plaque-related diseases

UC Santa Barbara scientists have made a discovery that has the potential for use in the early diagnosis and eventual treatment of plaque-related diseases such as Alzheimer's disease and Type 2 diabetes. Their work is published in a recent issue of Nature Chemistry.

10 Feb 2011

Full genetic blueprint of multiple prostate tumors laid bare

For the first time, researchers have laid bare the full genetic blueprint of multiple prostate tumors, uncovering alterations that have never before been detected and offering a deep view of the genetic missteps that underlie the disease. The study, made possible by key advances in whole genome sequencing and analysis, points to several new prostate cancer genes and a critical category of genomic changes as important drivers of prostate cancer growth.

10 Feb 2011

MEDTOX Scientific fourth quarter total revenues increase 25.7% to $25.0 million

MEDTOX Scientific, Inc. today announced fourth quarter and year-end results for the periods ended December 31, 2010.

10 Feb 2011

DNA sequencing of maternal blood plasma can accurately detect trisomy 21

In a study published online today in the American Journal of Obstetrics & Gynecology, researchers from the Sequenom Center for Molecular Medicine confirmed that DNA sequencing of maternal blood plasma could accurately detect trisomy 21.

10 Feb 2011

Cardiac Science receives contract to deploy Powerheart AEDs at US Postal Inspection Service

Cardiac Science Corporation, a global leader in automated external defibrillator and diagnostic cardiac monitoring devices, has been awarded a contract to deploy Powerheart AEDs at U.S. Postal Inspection Service sites across the nation.

10 Feb 2011

Scientists discover KCNH2 gene mutation in patients with long QT syndrome

Researchers from the Hospital Virgen de las Nieves of the University of Granada have identified the most frequent mutations in the gene KCNH2 in patients with long QT syndrome.

10 Feb 2011

BD and UCLB enter agreement for development of new diagnostics for ovarian, breast cancer

UCL Business (UCLB), a wholly owned subsidiary of University College London (UCL), and BD (Becton, Dickinson and Company), a leading global medical technology company, announced today an agreement aimed at improving the early detection of ovarian and breast cancers to ultimately enable earlier and more effective treatment.

From BD (Becton, Dickinson and Company) 10 Feb 2011

Myriad Genetics' 46-gene PROLARIS molecular diagnostic test predicts prostate cancer outcome

Myriad Genetics, Inc. announced today that a study published in Lancet Oncology shows the Company's 46-gene PROLARIS™ molecular diagnostic test significantly predicts prostate cancer outcome.

10 Feb 2011

Seaweed microsponges may help diagnose many diseases quickly, at far lower cost

Microsponges derived from seaweed may help diagnose heart disease, cancers, HIV and other diseases quickly and at far lower cost than current clinical methods. The microsponges are an essential component of Rice University's Programmable Bio-Nano-Chip (PBNC) and the focus of a new paper in the journal Small.

9 Feb 2011

PBNC technology may help detect cardiac disease, reduce diagnostic costs

Heart disease is a silent killer, but new microchip technology from Rice University is expected to advance the art of diagnosis.

9 Feb 2011

Funding too low for paediatric oncology research

At a time when the effects of paediatric oncology research have meant that more and more children survive cancer, its funding is too low and dependent on short-term grants to be able to sustain this improvement in the long-term, says a report supported by the EU-funded 7th Framework Programme project Eurocancercoms and published on-line in ecancer today.

9 Feb 2011

Aushon BioSystems enters diagnostic development collaboration with Peking University Cancer Hospital

Aushon BioSystems, Inc., a leading provider of multiplex immunoassay products and services announced that it has signed a letter of intent to enter into a diagnostic development collaboration with Peking University Cancer Hospital ("PUCH"), Beijing, China.

9 Feb 2011

Revo pacemaker receives FDA approval for use during certain MRI exams

The U.S. Food and Drug Administration today approved the first heart pacemaker designed to be used safely during certain magnetic resonance imaging (MRI) exams.

9 Feb 2011

FDA approves Medtronic's new Revo MRI pacemaker

Medtronic, today announced that the U.S. Food and Drug Administration approved its Revo MRI SureScan pacing system, the first and only pacemaker in the U.S. specifically designed for use in an Magnetic Resonance Imaging environment and approved as MR-Conditional. Shipments of Revo MRI will begin immediately.

8 Feb 2011

Abbott launches PLEX-ID Biothreat Assay to detect, distinguish 17 different pathogens

Abbott announced today that it has introduced the PLEX-ID Biothreat Assay, which is designed to detect and distinguish 17 different biothreat pathogens.

7 Feb 2011

Aetna, Tenet sign new multi-year agreement to access quality health care services

Tenet Healthcare Corporation and Aetna announced today that they have signed a new multi-year agreement.

7 Feb 2011

Diagnostic News and Research

Genetic tests find skeletons like incest in the family: Study

53 share a needle & HIV risk due to a clinic blunder

NIH awards Geospiza phase II SBIR grant to develop new DNA variant application for GeneSifter platform

Imaging Diagnostic Systems completes installation of CTLM breast imaging system in Jakarta, Indonesia

Scientists discover new method for early diagnosis, treatment of plaque-related diseases

Full genetic blueprint of multiple prostate tumors laid bare

MEDTOX Scientific fourth quarter total revenues increase 25.7% to $25.0 million

DNA sequencing of maternal blood plasma can accurately detect trisomy 21

Cardiac Science receives contract to deploy Powerheart AEDs at US Postal Inspection Service

Scientists discover KCNH2 gene mutation in patients with long QT syndrome

BD and UCLB enter agreement for development of new diagnostics for ovarian, breast cancer

Myriad Genetics' 46-gene PROLARIS molecular diagnostic test predicts prostate cancer outcome

Seaweed microsponges may help diagnose many diseases quickly, at far lower cost

PBNC technology may help detect cardiac disease, reduce diagnostic costs

Funding too low for paediatric oncology research

Aushon BioSystems enters diagnostic development collaboration with Peking University Cancer Hospital

Revo pacemaker receives FDA approval for use during certain MRI exams

FDA approves Medtronic's new Revo MRI pacemaker

Abbott launches PLEX-ID Biothreat Assay to detect, distinguish 17 different pathogens

Aetna, Tenet sign new multi-year agreement to access quality health care services

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News